STOCK TITAN

[6-K] MESOBLAST LTD Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Mesoblast Limited furnished a Form 6-K to provide investors with Australian Securities Exchange materials. The filing attaches two ASX documents dated October 28, 2025: an Appendix 3Y change of director’s interest notice and an Appendix 3G notification of issue, conversion or payment up of unquoted equity securities, incorporated by reference as Exhibits 99.1 and 99.2.

This update is administrative, making the ASX disclosures available to U.S. investors under the Exchange Act.

Mesoblast Limited ha fornito un modulo 6-K per fornire agli investitori materiali della Australian Securities Exchange. La presentazione allega due documenti ASX datati 28 ottobre 2025: una notifica di cambio interesse del direttore (Appendice 3Y) e una notifica di emissione, conversione o pagamento di strumenti di capitale non quotati, incorporati per riferimento come Esibiti 99.1 e 99.2.

Questo aggiornamento è amministrativo, rendendo disponibili le divulgazioni ASX agli investitori statunitensi ai sensi del Securities Exchange Act.

Mesoblast Limited presentó un Formulario 6-K para proporcionar a los inversionistas materiales de la Australian Securities Exchange. La presentación adjunta dos documentos de ASX con fecha 28 de octubre de 2025: un aviso de cambio de interés de director (Apéndice 3Y) y una notificación de emisión, conversión o pago de valores de acciones no cotizados, incorporados por referencia como Anexos 99.1 y 99.2.

Esta actualización es administrativa, poniendo a disposición de los inversionistas estadounidenses las divulgaciones de ASX conforme a la Ley de Intercambio.

Mesoblast Limited은 투자자들에게 Australian Securities Exchange 자료를 제공하기 위한 Form 6-K를 제출했다. 제출물에는 2025년 10월 28일자로 된 두 개의 ASX 문서가 첨부되어 있는데: 이사 선임 관련 이해관계 변경 통지(Appendix 3Y)와 비상장 주식의 발행, 전환 또는 지급 증가를 알리는 Appendix 3G 통지로, 각각 99.1과 99.2로서 참조로 포함되어 있다.

이번 업데이트는 행정적이며, ASX 공시를 증권거래법에 따라 미국 투자자들에게 제공하기 위한 것이다.

Mesoblast Limited a déposé un Form 6-K pour fournir aux investisseurs des matériaux de la Australian Securities Exchange. Le dépôt joint deux documents ASX datés du 28 octobre 2025 : un avis de changement d'intérêts du directeur (Annexe 3Y) et une notification d’émission, de conversion ou de paiement d’instruments de capitaux propres non cotés, incorporés par référence en tant qu’Exhibits 99.1 et 99.2.

Cette mise à jour est administrative, rendant les divulgations ASX disponibles pour les investisseurs américains en vertu du Securities Exchange Act.

Mesoblast Limited legte ein Form 6-K vor, um Investoren Materialien der Australian Securities Exchange bereitzustellen. Die Einreichung fügt zwei ASX-Dokumente vom 28. Oktober 2025 bei: eine Appendix 3Y-Benachrichtigung über Änderungen des Aufsichtsbereichs der Direktoren und eine Appendix 3G-Mitteilung über Ausgabe, Umwandlung oder Zahlung von nicht börsennotierten Eigenkapitalinstrumenten, die referenziert als Exhibits 99.1 und 99.2 eingebunden sind.

Dieses Update ist administrativ und macht die ASX-Offenlegungen für US-Investoren gemäß dem Exchange Act verfügbar.

Mesoblast Limited قدمت نموذج 6-K لتزويد المستثمرين بمواد من Australian Securities Exchange. ترفق الطلب وثيقتين من ASX مؤرختين 28 أكتوبر 2025: إشعار تغيير مصالح مدير (الملحق 3Y) وإشعار إصدار أو تحويل أو سداد أسهم حقوق ملكية غير مدرجة (الملحق 3G)، المعتبرة كمرفقين 99.1 و99.2.

هذا التحديث إداري، يجعل الإفصاءات الخاصة بالـ ASX متاحة للمستثمرين الأميركيين وفقًا لـ Exchange Act.

Positive
  • None.
Negative
  • None.

Mesoblast Limited ha fornito un modulo 6-K per fornire agli investitori materiali della Australian Securities Exchange. La presentazione allega due documenti ASX datati 28 ottobre 2025: una notifica di cambio interesse del direttore (Appendice 3Y) e una notifica di emissione, conversione o pagamento di strumenti di capitale non quotati, incorporati per riferimento come Esibiti 99.1 e 99.2.

Questo aggiornamento è amministrativo, rendendo disponibili le divulgazioni ASX agli investitori statunitensi ai sensi del Securities Exchange Act.

Mesoblast Limited presentó un Formulario 6-K para proporcionar a los inversionistas materiales de la Australian Securities Exchange. La presentación adjunta dos documentos de ASX con fecha 28 de octubre de 2025: un aviso de cambio de interés de director (Apéndice 3Y) y una notificación de emisión, conversión o pago de valores de acciones no cotizados, incorporados por referencia como Anexos 99.1 y 99.2.

Esta actualización es administrativa, poniendo a disposición de los inversionistas estadounidenses las divulgaciones de ASX conforme a la Ley de Intercambio.

Mesoblast Limited은 투자자들에게 Australian Securities Exchange 자료를 제공하기 위한 Form 6-K를 제출했다. 제출물에는 2025년 10월 28일자로 된 두 개의 ASX 문서가 첨부되어 있는데: 이사 선임 관련 이해관계 변경 통지(Appendix 3Y)와 비상장 주식의 발행, 전환 또는 지급 증가를 알리는 Appendix 3G 통지로, 각각 99.1과 99.2로서 참조로 포함되어 있다.

이번 업데이트는 행정적이며, ASX 공시를 증권거래법에 따라 미국 투자자들에게 제공하기 위한 것이다.

Mesoblast Limited a déposé un Form 6-K pour fournir aux investisseurs des matériaux de la Australian Securities Exchange. Le dépôt joint deux documents ASX datés du 28 octobre 2025 : un avis de changement d'intérêts du directeur (Annexe 3Y) et une notification d’émission, de conversion ou de paiement d’instruments de capitaux propres non cotés, incorporés par référence en tant qu’Exhibits 99.1 et 99.2.

Cette mise à jour est administrative, rendant les divulgations ASX disponibles pour les investisseurs américains en vertu du Securities Exchange Act.

Mesoblast Limited legte ein Form 6-K vor, um Investoren Materialien der Australian Securities Exchange bereitzustellen. Die Einreichung fügt zwei ASX-Dokumente vom 28. Oktober 2025 bei: eine Appendix 3Y-Benachrichtigung über Änderungen des Aufsichtsbereichs der Direktoren und eine Appendix 3G-Mitteilung über Ausgabe, Umwandlung oder Zahlung von nicht börsennotierten Eigenkapitalinstrumenten, die referenziert als Exhibits 99.1 und 99.2 eingebunden sind.

Dieses Update ist administrativ und macht die ASX-Offenlegungen für US-Investoren gemäß dem Exchange Act verfügbar.

Mesoblast Limited قدمت نموذج 6-K لتزويد المستثمرين بمواد من Australian Securities Exchange. ترفق الطلب وثيقتين من ASX مؤرختين 28 أكتوبر 2025: إشعار تغيير مصالح مدير (الملحق 3Y) وإشعار إصدار أو تحويل أو سداد أسهم حقوق ملكية غير مدرجة (الملحق 3G)، المعتبرة كمرفقين 99.1 و99.2.

هذا التحديث إداري، يجعل الإفصاءات الخاصة بالـ ASX متاحة للمستثمرين الأميركيين وفقًا لـ Exchange Act.

Mesoblast Limited 提交了一份 Form 6-K,为投资者提供澳大利亚证券交易所的材料。该备案包含两份 ASX 文件,日期为 2025 年 10 月 28 日:一份为董事兴趣变动通知的附录 3Y,以及一份为未上市股票的发行、转换或偿付通知的附录 3G,作为展品 99.1 和 99.2 引用并纳入。

此次更新是行政性的,使美国投资者能够根据《交易法》获得 ASX 报披露信息。


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
For the month of October 2025
Commission File Number 001-37626
Mesoblast Limited
(Exact name of Registrant as specified in its charter)
Not Applicable
(Translation of Registrant’s name into English)
Australia
(
Jurisdiction of incorporation or organization)

Silviu Itescu
Chief Executive Officer and Executive Director
Level 38
55 Collins Street
Melbourne 3000
Australia
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:
Form 20-F Form 40-F





INFORMATION CONTAINED ON THIS REPORT ON FORM 6-K
On October 28, 2025, Mesoblast Limited filed with the Australian Securities Exchange a new issue announcement, change of director’s interest notice (Appendix 3Y) which is attached hereto as Exhibit 99.1, and is incorporated herein by reference.
On October 28, 2025, Mesoblast Limited filed with the Australian Securities Exchange a new issue announcement, notification of issue, conversion or payment up of unquoted equity securities (Appendix 3G) which is attached hereto as Exhibit 99.2, and is incorporated herein by reference.




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized.

Mesoblast Limited
/s/ Niva Sivakumar
Niva Sivakumar
Company Secretary
Dated: October 29, 2025



INDEX TO EXHIBITS
Item
 99.1
Appendix 3Y of Mesoblast Ltd, dated October 28, 2025.
 99.2
Appendix 3G of Mesoblast Ltd, dated October 28, 2025.




FAQ

What did Mesoblast (MESO) file on Form 6-K?

Mesoblast filed a Form 6-K that furnishes two ASX announcements: Appendix 3Y and Appendix 3G, both dated October 28, 2025, as Exhibits 99.1 and 99.2.

What is included in Exhibit 99.1 for MESO?

Exhibit 99.1 is an Appendix 3Y, a change of director’s interest notice filed with the ASX on October 28, 2025.

What is included in Exhibit 99.2 for MESO?

Exhibit 99.2 is an Appendix 3G, a notification of issue, conversion or payment up of unquoted equity securities filed with the ASX on October 28, 2025.

Why did Mesoblast (MESO) submit these ASX documents via Form 6-K?

The Form 6-K incorporates the ASX filings by reference to make the disclosures available to U.S. investors under the Exchange Act.

Does the Form 6-K disclose financial results for MESO?

No. The Form 6-K furnishes administrative ASX notices (Appendix 3Y and 3G); it does not include earnings data.

When was the Form 6-K dated?

The signature page is dated October 29, 2025.
Mesoblast

NASDAQ:MESO

MESO Rankings

MESO Latest News

MESO Latest SEC Filings

MESO Stock Data

2.10B
121.76M
0.09%
2.68%
1.89%
Biotechnology
Healthcare
Link
Australia
Melbourne